Bill Text: CA AB2132 | 2023-2024 | Regular Session | Amended
Bill Title: Health care services: tuberculosis.
Spectrum: Partisan Bill (Democrat 6-0)
Status: (Passed) 2024-09-29 - Chaptered by Secretary of State - Chapter 951, Statutes of 2024. [AB2132 Detail]
Download: California-2023-AB2132-Amended.html
Amended
IN
Senate
August 15, 2024 |
Amended
IN
Senate
June 25, 2024 |
Amended
IN
Senate
June 10, 2024 |
Amended
IN
Assembly
February 27, 2024 |
Introduced by Assembly Member Low (Coauthors: Assembly Members Ting, Mike Fong, and Gipson) (Coauthors: Senators Durazo and Wiener) |
February 06, 2024 |
LEGISLATIVE COUNSEL'S DIGEST
Digest Key
Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NOBill Text
The people of the State of California do enact as follows:
SECTION 1.
The Legislature finds and declares all of the following:(a)A patient who is 18 year of age or older and who receives health care services in a facility, clinic, center, office, or other setting, where primary care services are provided, shall be offered the
tuberculosis (TB) risk assessment distributed by the State Department of Public Health and TB screening test, if TB risk factors are identified, to the extent these services are covered under the patient’s health care coverage, based on the latest screening indications recommended by the United States Preventive Services Task Force.
(b)Subdivision (a) does not apply if any of the following situations exist unless a health care provider determines that the TB risk assessment, TB screening test, or both, should be offered again:
(1)The patient is being treated for a life-threatening emergency.
(2)The patient has previously been the subject of the TB risk assessment, TB screening test, or both, and has no new TB risk factors since the last TB risk assessment or TB screening test.
(3)(A)The patient has had a documented, previously positive Interferon-Gamma Release Assay (IGRA) test or has previously tested positive for a latent TB infection (LTBI).
(B)If the patient has no documented followup health care, followup is required in accordance with subdivision (c).
(4)The patient lacks capacity to consent to the TB risk assessment, TB screening test, or both.
(c)If a patient accepts the offer of the TB screening test and the test is positive, a health care provider shall offer the patient followup health care or refer the patient to a health care provider who can provide followup health care.
(d)This section does not apply to the emergency department of a general acute care hospital as defined in subdivision (a) of Section 1250.
(e)This section shall not affect the scope of practice of any health care provider or diminish any authority or legal or professional obligation of any health care provider to offer a TB risk assessment, TB screening test, or both, or to provide services or care for the patient of a TB risk assessment, TB screening test, or both.
(f)A health care provider that fails to comply with the requirements of this section shall not be subject to any disciplinary actions related to their licensure or certification, or to any civil or criminal liability, because of the health care provider’s failure to comply with the requirements of this
section.
(g)Section 1290 does not apply to a violation of this section.
(h)
The State Department of Public Health shall do both of the following:
(1)Work with stakeholders, including, but not limited to, primary care clinics, health care providers, and TB experts, to implement this section.
(2)Notify primary care facilities about the requirements of this section.
(i)For purposes of this section, the following definitions apply:
(1)“Followup health care” includes evaluating the patient for a diagnosis of TB infection or active TB disease and providing medical management and treatment according to the latest clinical practice guidelines recommended by the federal Centers for Disease Control and Prevention, the American Thoracic Society, or the State Department of Public Health for California-specific TB management.
(2)“Tuberculosis risk assessment” or “TB risk assessment” means the California Adult Tuberculosis Risk Assessment and User Guide developed by the State Department of Public Health, in consultation with the California Tuberculosis Controllers Association, to be used to conduct TB risk assessments and identify TB risk factors pursuant to this section.
(3)“Tuberculosis screening test” or “TB screening test” means either an approved intradermal tuberculin skin test (TST), IGRA blood test, which is the preferred approach, or any other test for TB infection that is recommended by the federal Centers for Disease Control and Prevention and licensed by the United States Food and Drug Administration.